• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Sigyn Therapeutics Inc (OP:SIGY)

1.710 UNCHANGED
Last Price Updated: 11:39 AM EST, Dec 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 1.710
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 1.710
Today's Range 1.710 - 1.710
52wk Range 1.400 - 5.000
Shares Outstanding N/A
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Sigyn CEO Note: First-In-Industry Attributes of CardioDialysisTM to Treat Cardiovascular Disease
December 11, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Sigyn CEO Note: First-In-Industry Attributes of CardioDialysisTM to Treat Cardiovascular Disease
December 11, 2025
Via TheNewswire.com

Performance

YTD
-46.6%
-46.6%
1 Month
-14.5%
-14.5%
3 Month
-54.4%
-54.4%
6 Month
-38.9%
-38.9%
1 Year
-46.6%
-46.6%

More News

Read More
News headline image
Sigyn CEO Note: Nature Publication Reinforces Rationale for CardioDialysisTM to Address Cardiovascular Disease in Dialysis Patients
December 03, 2025
Via NewMediaWire
Sigyn CEO Note: Nature Publication Reinforces Rationale for CardioDialysisTM to Address Cardiovascular Disease in Dialysis Patients
December 03, 2025
Via TheNewswire.com
News headline image
Sigyn CardioDialysis(TM) Featured on the Big Biz Show
November 18, 2025
Via NewMediaWire
Topics Death
Sigyn Therapeutics Announces Cardiovascular Disease Study
September 03, 2025
Via TheNewswire.com
Topics Death
Sigyn CardioDialysis(TM) Featured on the Big Biz Show
November 18, 2025
Via TheNewswire.com
Topics Death
Sigyn Therapeutics Reports Third Quarter Financial Results and Subsequent Introduction of CardioDialysis(TM)
November 14, 2025
Via TheNewswire.com
Topics Intellectual Property
News headline image
Sigyn Therapeutics Reports Third Quarter Financial Results and Subsequent Introduction of CardioDialysis(TM)
November 14, 2025
Via NewMediaWire
Topics Intellectual Property
News headline image
Sigyn Therapeutics Releases Shareholder Letter to Introduce CardioDialysis(TM)
November 06, 2025
Via NewMediaWire
Topics Intellectual Property
Sigyn Therapeutics Releases Shareholder Letter to Introduce CardioDialysis(TM)
November 06, 2025
Via TheNewswire.com
Topics Intellectual Property
News headline image
Life Sciences Virtual Investor Forum: Presentations Now Available for Online Viewing
September 18, 2025
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
Sigyn Therapeutics to Present at the Life Sciences Virtual Investor Forum on September 18th
September 16, 2025
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
Life Science Virtual Investor Forum Agenda Announced for September 18th
September 16, 2025
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
Sigyn Therapeutics Appoints Dr. Christoph Zaba to Its Scientific Advisory Board
September 11, 2025
Via NewMediaWire
Sigyn Therapeutics Appoints Dr. Christoph Zaba to Its Scientific Advisory Board
September 11, 2025
Via TheNewswire.com
News headline image
Sigyn Therapeutics Announces Cardiovascular Disease Study
September 03, 2025
Via NewMediaWire
Topics Death
News headline image
RETRANSMISSION: Goldman Small Cap Research Publishes New Research Report on Sigyn Therapeutics Inc.
July 01, 2025
Via ACCESS Newswire
News headline image
Goldman Small Cap Research Publishes New Research Report on Sigyn Therapeutics Inc.
July 01, 2025
Via ACCESS Newswire
News headline image
Sigyn CEO Note: An Emerging New Industry, 15 Years in the Making
March 12, 2025
Via NewMediaWire
Topics Death
Sigyn CEO Note: An Emerging New Industry, 15 Years in the Making
March 12, 2025
Via TheNewswire.com
Topics Death
News headline image
Sigyn CEO Note: Combating the Rising Threat of New Pandemic Viruses
March 05, 2025
Via NewMediaWire
Sigyn CEO Note: Combating the Rising Threat of New Pandemic Viruses
March 05, 2025
Via TheNewswire.com
News headline image
Sigyn Therapeutics to be Featured in Fireside Chat With Zacks Healthcare Analyst
February 25, 2025
Via NewMediaWire
Sigyn Therapeutics to be Featured in Fireside Chat With Zacks Healthcare Analyst
February 25, 2025
Via TheNewswire.com

Frequently Asked Questions

Is Sigyn Therapeutics Inc publicly traded?
Yes, Sigyn Therapeutics Inc is publicly traded.
What exchange does Sigyn Therapeutics Inc trade on?
Sigyn Therapeutics Inc trades on the OTC Traded
What is the ticker symbol for Sigyn Therapeutics Inc?
The ticker symbol for Sigyn Therapeutics Inc is SIGY on the OTC Traded
What is the current price of Sigyn Therapeutics Inc?
The current price of Sigyn Therapeutics Inc is 1.710
When was Sigyn Therapeutics Inc last traded?
The last trade of Sigyn Therapeutics Inc was at 12/16/25 11:39 AM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap